40^th European Cardiology Conference

Cardiomyopathies and Myocardial Diseases

Cardiomyopathies and myocardial diseases encompass a range of conditions that affect the heart muscle, leading to its dysfunction and impacting the heart's ability to pump blood effectively. These conditions can result from genetic factors, infections, inflammatory diseases, or other underlying health issues. Cardiomyopathies are generally classified into three main types: dilated, hypertrophic, and restrictive, each with distinct characteristics and management strategies. Dilated cardiomyopathy is the most common form, where the heart chambers enlarge, reducing its pumping capacity. Hypertrophic cardiomyopathy involves thickening of the heart muscle, which can obstruct blood flow and lead to arrhythmias. Restrictive cardiomyopathy is marked by rigid heart walls that impair the heart's ability to fill with blood properly. Myocardial diseases include conditions like myocarditis, an inflammation of the heart muscle often caused by viral infections, and myocardial infarction, which occurs due to a blockage in the coronary arteries leading to tissue damage. Advances in genetic testing, imaging technologies, and treatment options have improved the diagnosis and management of these diseases. New therapies, including targeted medications, device-based interventions, and stem cell therapy, offer hope for improved outcomes. Early detection and ongoing research continue to enhance care and quality of life for individuals affected by these conditions.